These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 15206668

  • 1. Improved potency of escitalopram on the human serotonin transporter: demonstration of an ex vivo assay technique.
    Rausch JL, Corley KM, Hobby HM.
    J Clin Psychopharmacol; 2004 Apr; 24(2):209-13. PubMed ID: 15206668
    [Abstract] [Full Text] [Related]

  • 2. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities.
    Sánchez C, Bergqvist PB, Brennum LT, Gupta S, Hogg S, Larsen A, Wiborg O.
    Psychopharmacology (Berl); 2003 Jun; 167(4):353-62. PubMed ID: 12719960
    [Abstract] [Full Text] [Related]

  • 3. [Second generation SSRIS: human monoamine transporter binding profile of escitalopram and R-fluoxetine].
    Owens JM, Knight DL, Nemeroff CB.
    Encephale; 2002 Jun; 28(4):350-5. PubMed ID: 12232544
    [Abstract] [Full Text] [Related]

  • 4. The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors.
    Chen F, Larsen MB, Sánchez C, Wiborg O.
    Eur Neuropsychopharmacol; 2005 Mar; 15(2):193-8. PubMed ID: 15695064
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological characterization of the cloned human 5-hydroxytryptamine transporter.
    Agnel M, Esnaud H, Langer SZ, Graham D.
    Biochem Pharmacol; 1996 May 03; 51(9):1145-51. PubMed ID: 8645336
    [Abstract] [Full Text] [Related]

  • 6. Escitalopram, an antidepressant with an allosteric effect at the serotonin transporter--a review of current understanding of its mechanism of action.
    Zhong H, Haddjeri N, Sánchez C.
    Psychopharmacology (Berl); 2012 Jan 03; 219(1):1-13. PubMed ID: 21901317
    [Abstract] [Full Text] [Related]

  • 7. Escitalopram: a unique mechanism of action.
    Bræstrup C, Sanchez C.
    Int J Psychiatry Clin Pract; 2004 Jan 03; 8 Suppl 1():11-3. PubMed ID: 24930683
    [Abstract] [Full Text] [Related]

  • 8. The interaction of escitalopram and R-citalopram at the human serotonin transporter investigated in the mouse.
    Jacobsen JP, Plenge P, Sachs BD, Pehrson AL, Cajina M, Du Y, Roberts W, Rudder ML, Dalvi P, Robinson TJ, O'Neill SP, Khoo KS, Morillo CS, Zhang X, Caron MG.
    Psychopharmacology (Berl); 2014 Dec 03; 231(23):4527-40. PubMed ID: 24810106
    [Abstract] [Full Text] [Related]

  • 9. New 3-[4-(2,3-dihydro-14-benzodioxin-5-yl)piperazin-1-yl]-1-(5-substituted benzo[b]thiophen-3-yl)propanol derivatives with dual action at 5-HT(1A) serotonin receptors and serotonin transporter as a new class of antidepressants.
    Silanes SP, Orús L, Oficialdegui AM, Martínez Esparza J, Lasheras B, Del Río J, Monge A.
    Pharmazie; 2004 Jul 03; 59(7):499-501. PubMed ID: 15296084
    [Abstract] [Full Text] [Related]

  • 10. No effect of six weeks of treatment with escitalopram on mood in healthy volunteers--irrespective of genotype for the promoter of the serotonin transporter.
    Kellner M, Demiralay C, Muhtz C, Husemann J, Kölsch W, Hiemke C, Yassouridis A, Wiedemann K.
    Psychiatry Res; 2008 Dec 15; 161(3):339-43. PubMed ID: 18962988
    [Abstract] [Full Text] [Related]

  • 11. Specific effects of escitalopram on neuroendocrine response.
    Hawken ER, Owen JA, Hudson RW, Delva NJ.
    Psychopharmacology (Berl); 2009 Nov 15; 207(1):27-34. PubMed ID: 19662384
    [Abstract] [Full Text] [Related]

  • 12. Studies toward the discovery of the next generation of antidepressants. Part 2: incorporating a 5-HT(1A) antagonist component into a class of serotonin reuptake inhibitors.
    Mewshaw RE, Meagher KL, Zhou P, Zhou D, Shi X, Scerni R, Smith D, Schechter LE, Andree TH.
    Bioorg Med Chem Lett; 2002 Feb 11; 12(3):307-10. PubMed ID: 11814784
    [Abstract] [Full Text] [Related]

  • 13. Structure, function and regulation of the 5-hydroxytryptamine (serotonin) transporter.
    Horschitz S, Hummerich R, Schloss P.
    Biochem Soc Trans; 2001 Nov 11; 29(Pt 6):728-32. PubMed ID: 11709064
    [Abstract] [Full Text] [Related]

  • 14. In vivo investigation of escitalopram's allosteric site on the serotonin transporter.
    Murray KE, Ressler KJ, Owens MJ.
    Pharmacol Biochem Behav; 2016 Feb 11; 141():50-7. PubMed ID: 26621784
    [Abstract] [Full Text] [Related]

  • 15. New 3-[4-(3-substituted phenyl)piperazin-1-yl]-1-(benzo[b]thiophen-3-yl)propanol derivatives with dual action at 5-HT1A serotonin receptors and serotonin transporter as a new class of antidepressants.
    Orús L, Martínez J, Pérez S, Oficialdegui AM, del Castillo JC, Mourelle M, Lasheras B, del Río J, Monge A.
    Pharmazie; 2002 Aug 11; 57(8):515-8. PubMed ID: 12227188
    [Abstract] [Full Text] [Related]

  • 16. Escitalopram: a review of its use in the management of anxiety disorders.
    Dhillon S, Scott LJ, Plosker GL.
    CNS Drugs; 2006 Aug 11; 20(9):763-90. PubMed ID: 16953656
    [Abstract] [Full Text] [Related]

  • 17. Platelet 5-hydroxytryptamine (5-HT) transporter and 5-HT2A receptor binding after chronic hypercorticosteronemia, (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane administration or neurotoxin-induced depletion of central nervous system 5-HT in the rat.
    Owens MJ, Ballenger CA, Knight DL, Nemeroff CB.
    J Pharmacol Exp Ther; 1996 Sep 11; 278(3):1040-9. PubMed ID: 8819484
    [Abstract] [Full Text] [Related]

  • 18. There is a new antidepressant escitalopram (Lexapro) that is a cousin of citalopram (Celexa). How are these two different and does the newer drug have any advantages?
    Harv Ment Health Lett; 2003 Jul 11; 20(1):8. PubMed ID: 12888468
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. High affinity recognition of serotonin transporter antagonists defined by species-scanning mutagenesis. An aromatic residue in transmembrane domain I dictates species-selective recognition of citalopram and mazindol.
    Barker EL, Perlman MA, Adkins EM, Houlihan WJ, Pristupa ZB, Niznik HB, Blakely RD.
    J Biol Chem; 1998 Jul 31; 273(31):19459-68. PubMed ID: 9677366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.